Lancet study: Russia's Sputnik V vaccine 91.6% effective

On February, 2 the world's oldest and prominent medical journal The Lancet has published an article, dedicated to the Russian vaccine for COVID-19, which was developed by the Gamaleya National Center of Epidemiology and Microbiology (Moscow, Russia). According to results published in The Lancet, Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19.

For more information follow the direct link to view the article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext